Stay updated on Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.

Latest updates to the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label changed from v3.5.3 to v3.5.4. This update does not modify study details or data presented on the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA location spelling is corrected so the Parramatta, New South Wales site name is consistent. The page’s revision/version label is updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision: v3.4.3 added; Revision: v3.4.2 removed.SummaryDifference0.0%

- Check94 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice (v3.4.1). These are administrative updates and do not affect the study details or user-facing content.SummaryDifference0.2%

Stay in the know with updates to Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Efficacy in Active Psoriatic Arthritis Clinical Trial page.